BJ
SUPN icon

BlackRock Japan’s Supernus Pharmaceuticals SUPN Stock Holding History

BlackRock Japan’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$29K Sell
1,141
-2,292
-67% -$51.2K ﹤0.01% 1070
2016
Q3 		$85K Buy
3,433
+1,141
+50% +$25.8K ﹤0.01% 904
2016
Q2 		$47K Buy
+2,292
New +$40.7K ﹤0.01% 1005

Other funds holding SUPN

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock Japan's SUPN Position: Q4 2016 in Review

BlackRock Japan reduced its Supernus Pharmaceuticals (SUPN) stake by 67% in Q4 2016, selling an estimated $51.2K and leaving 1,141 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #1070.

BlackRock Japan first reported a position in SUPN in Q2 2016 and has held it in 3 quarters since. The position peaked at $85K in Q3 2016. 234 funds tracked by Wall St. Rank hold SUPN as of Q4 2016.

  • BlackRock Japan held 1,141 shares of Supernus Pharmaceuticals worth $29K as of Q4 2016.
  • BlackRock Japan sold 2,292 Supernus Pharmaceuticals shares in Q4 2016, an estimated $51.2K.
  • Supernus Pharmaceuticals made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1070 holding.
  • BlackRock Japan first reported a position in Supernus Pharmaceuticals in Q2 2016 and has held it in 3 quarters since.
  • BlackRock Japan's Supernus Pharmaceuticals position peaked at $85K in Q3 2016.
  • 234 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.